NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-21

  1. 468 Posts.
    lightbulb Created with Sketch. 260
    Woohoo! Congrats everyone! The p-values look great.

    I’m actually crying. I have to be honest, I lost the plot after the Culper Report dropped (which is why I stopped posting). This was the big one for me - additional validation of NNZ-2591. BP’s going to have to ante up!

    Enjoy the day folks! Apart from my selfishness, I’m so happy for the PH community.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.